Results showed clinical improvement in treatment of peri-implantitis, however, no significant differences in tissue inhibitor metalloproteinase-1 or matrix metalloproteinase-9 levels between the Diode and control groups [32]. The gene discussed is MMP9; the disease is Peri-Implantitis.